[Lamiktal in the treatment of epilepsy patients].
Lamictal (Lamotrigin) action was studied in 61 patients with partial and generalized epileptic seizures (not fewer than twice a month). Most of the patients received Lamictal in doses of 200-300 mg daily as well as other antiepileptic medications (before lamictal all patients were treated without effect with various antiepileptic medications). Effectiveness of treatment with lamictal includes: the cessation of epileptic attacks (5 patients), its more rare appearance (31 patients), transformation into more light fits (15 patients). Lamictal has a broad spectrum of antiepileptic activity: it stops generalized tonic-clonic seizures, absences, simple and complex partial seizures as well as secondarily generalized tonic-clonic seizures. The medication is also effective in patients with psychopathologic symptoms.
Bakunts
G O
GO
Burd
G S
GS
Vaĭntrub
M Ia
MIa
Karlov
V A
VA
Savchenko
Iu N
IuN
Solovykh
N N
NN
Shershever
A S
AS
Shprakh
V V
VV
D000293:Adolescent; D000328:Adult; D000927:Anticonvulsants / Q000008:administration & dosage* / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D004828:Epilepsies, Partial / Q000188:drug therapy* / Q000523:psychology; D004829:Epilepsy, Generalized / Q000188:drug therapy* / Q000523:psychology; D005260:Female; D006801:Humans; D000077213:Lamotrigine; D008297:Male; D008875:Middle Aged; D009484:Neuropsychology; D013997:Time Factors; D014227:Triazines / Q000008:administration & dosage* / Q000009:adverse effects
D000927:Anticonvulsants; D014227:Triazines; D000077213:Lamotrigine
Lamiktal v lechenii bol'nykh épilepsieĭ.